NoileImmune Biotech Inc (4893)

Tokyo
Currency in JPY
188.00
-2.00(-1.05%)
Closed
4893 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
187.00191.00
52 wk Range
121.00353.00
Key Statistics
Edit
Bid/Ask
188.00 / 189.00
Prev. Close
190
Open
190
Day's Range
187-191
52 wk Range
121-353
Volume
307.6K
Average Volume (3m)
635.78K
1-Year Change
-4.02%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4893 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
440.00
Upside
+134.04%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

NoileImmune Biotech Company Profile

Noile-Immune Biotech Inc. researches and develops CAR-T cells for cancer immunotherapies. The company was incorporated in 2015 and is headquartered in Minato, Japan.

Compare 4893 to Peers and Sector

Metrics to compare
4893
Peers
Sector
Relationship
P/E Ratio
−7.7x−5.2x−0.6x
PEG Ratio
−0.36−0.260.00
Price/Book
1.7x4.1x2.6x
Price / LTM Sales
1,169.1x69.6x3.1x
Upside (Analyst Target)
131.6%50.1%52.8%
Fair Value Upside
Unlock8.0%8.4%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 440.00
(+134.04% Upside)

Earnings

Latest Release
Nov 14, 2024
EPS / Forecast
-2.39 / 15.79
Revenue / Forecast
3.00M / 2.61M
EPS Revisions
Last 90 days

FAQ

What Is the NoileImmune Biotech (4893) Stock Price Today?

The NoileImmune Biotech stock price today is 188.00

What Stock Exchange Does NoileImmune Biotech Trade On?

NoileImmune Biotech is listed and trades on the Tokyo stock exchange.

What Is the Stock Symbol for NoileImmune Biotech?

The stock symbol for NoileImmune Biotech is "4893."

What Is the NoileImmune Biotech Market Cap?

As of today, NoileImmune Biotech market cap is 8.23B.

What is NoileImmune Biotech Earnings Per Share?

The NoileImmune Biotech EPS is -24.64.

What Is the Next NoileImmune Biotech Earnings Date?

NoileImmune Biotech will release its next earnings report on 14 Feb 2025.

From a Technical Analysis Perspective, Is 4893 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.